chr16-81139516-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The ENST00000525539.5(PKD1L2):c.5614C>T(p.Pro1872Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000106 in 1,409,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
PKD1L2
ENST00000525539.5 missense
ENST00000525539.5 missense
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.52
Genes affected
PKD1L2 (HGNC:21715): (polycystin 1 like 2 (gene/pseudogene)) This gene encodes a member of the polycystin protein family. This protein may function as a G-protein-coupled component or regulator of cation channel pores. The long isoform of this protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. This gene is a polymorphic pseudogene in humans. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
BayesDel_noAF computational evidence supports a deleterious effect, 0.52
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1L2 | NR_126532.3 | n.5629C>T | non_coding_transcript_exon_variant | 32/43 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1L2 | ENST00000525539.5 | c.5614C>T | p.Pro1872Ser | missense_variant | 32/43 | 1 | ENSP00000434417.1 | |||
PKD1L2 | ENST00000533478.5 | c.3559C>T | p.Pro1187Ser | missense_variant | 21/32 | 1 | ENSP00000434644.1 | |||
PKD1L2 | ENST00000530363.5 | n.203+1781C>T | intron_variant | 1 | ||||||
PKD1L2 | ENST00000299598.11 | n.5011C>T | non_coding_transcript_exon_variant | 22/25 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.0000106 AC: 15AN: 1409542Hom.: 0 Cov.: 30 AF XY: 0.0000129 AC XY: 9AN XY: 696224
GnomAD4 exome
AF:
AC:
15
AN:
1409542
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
696224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.5614C>T (p.P1872S) alteration is located in exon 32 (coding exon 32) of the PKD1L2 gene. This alteration results from a C to T substitution at nucleotide position 5614, causing the proline (P) at amino acid position 1872 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Pathogenic
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at